Mr. Dean Burns reports

OCUMETICS COMPLETES ONE-MONTH POSTOPERATIVE EXAMINATIONS - RESULTS PENDING

Ocumetics Technology Corp. has completed one-month postoperative examinations of the first patients who were implanted with the Ocumetics Accommodating Intraocular Lens in Mexico City on Aug. 15, 2025.

"On Friday, Sept. 12, we performed one-month postoperative examinations of our first patients implanted with the Ocumetics Lens," said Dean Burns, president and chief executive officer of Ocumetics Technology. "During the examinations we observed progress with recovery and completed a number of visual acuity measurements. Our team will analyze patient clinical reports early this week and provide an update shortly," adds Mr. Burns.

The company's first-in-human clinical protocol was strategically designed to address three patient groups. The company is currently proceeding with group 1 patients. Surgeries for the second and final day of group 1 patients are scheduled for Sept. 24, 2025.

The end points for each group are focused on the following key areas of evaluation:

Primary end points:

• Safety -- establishing a clear baseline of patient health and recovery;
• Distance vision correction -- assessing the Ocumetics Lens's ability to restore far vision.

Secondary end points:

• Product handling and surgical delivery -- ensuring procedural efficiency and reliability;
• Near reading ability -- evaluating the Ocumetics Len's ability to restore close-range vision.

About Ocumetics Technology Corp.

Ocumetics Technology is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the preclinical study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.

We seek Safe Harbor.